EDGAR Filing Documents for 0000893220-08-002676

Form 8-K - Current report:

SEC Accession No. 0000893220-08-002676

Filing Date

2008-10-06

Accepted

2008-10-06 17:09:29

Documents

Period of Report

2008-09-30

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K ECHO THERAPEUTICS, INC.	w71047e8vk.htm	8-K	29511
2	EXHIBIT 4.1	w71047exv4w1.htm	EX-4.1	49165
3	EXHIBIT 10.1	w71047exv10w1.htm	EX-10.1	65629
4	EXHIBIT 99.1	w71047exv99w1.htm	EX-99.1	84711
	Complete submission text file	0000893220-08-002676.txt		231111

Mailing Address 10 FORGE PARKWAY FRANKLIN MA 02038

Business Address 10 FORGE PARKWAY FRANKLIN MA 02038 508 553-8850

Echo Therapeutics, Inc. (Filer) CIK: 0001031927 (see all company filings)